Hepatocellular carcinoma: The virus or the liver?-Reference-Cited by-同舟云学术

Hepatocellular carcinoma: The virus or the liver?

Published:2022-03-29 Issue: Volume: Page:
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Papatheodoridi Alkistis¹,Papatheodoridis George²^ORCID

Affiliation:

1. Department of Clinical Therapeutics, Medical School of National and Kapodistrian University of Athens “Alexandra” General Hospital of Athens Athens Greece

2. Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens School of Health Sciences General Hospital of Athens “Laiko” Athens Greece

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15253

Reference93 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2021

2. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma;Galle PR;J Hepatol,2018

3. Human viral oncogenesis: a cancer hallmarks analysis;Mesri EA;Cell Host Microbe,2014

4. Structure, sequence and expression of the hepatitis delta (delta) viral genome;Wang KS;Nature,1986

5. The hepatitis delta virus: replication and pathogenesis;Sureau C;J Hepatol,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma;Liver International;2024-03

2. Hepatitis Delta: Ready for primetime?;Liver International;2023-08

3. EASL Clinical Practice Guidelines on hepatitis delta virus;Journal of Hepatology;2023-08

4. Phosphorylated PTTG1 switches its subcellular distribution and promotes β-catenin stabilization and subsequent transcription activity;Oncogene;2023-07-03

5. HERACLIS‐HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg‐positive patients;Liver International;2023-06-08